VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Technology Scientific & Technical Instruments

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by Sonny7on Dec 01, 2015 11:32pm

104 Views

Post# 24345436

RE:Has anyone seen this?

The TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement.

Number of securities: 9,090,909 common share units (Each unit consists of one common share in the share capital of the company and one-fourth of one share purchase warrant.)

Purchase price: 5.5 cents per unit

Warrants: 2,272,727 share purchase warrants to purchase 2,272,727 shares

Warrant exercise price: 11 cents for up to 24 months from date of issuance

Number of placees: one placee

Finder's fee: $40,000 cash and 727,272 warrants

Bullboard Posts

The top 10 Canadian medical stocks